Physician profile
Mina Baskhron
NPI 1457791881
$6,213.79
in general payments reported to CMS, 2019-2025
23 companies · $605 in 2025
The $605 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $152 · 2021: $675 · 2022: $1,706 · 2023: $2,123 · 2024: $627 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407 · Travel and Lodging: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,406.68 |
| Travel and Lodging | $948.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,034.62 | 2019-2025 | Salvation, Hoffmann, Prostep Mica |
| Paragon 28, INC. | $860.29 | 2022-2023 | Phantom Metatarsal Shortening |
| Kerecis Limited | $210.08 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $172.59 | 2025 | Restrata Wound Matrix |
| Royal Biologics, INC. | $161.67 | 2021 | |
| Treace Medical Concepts, INC. | $135.90 | 2023-2025 | |
| Smith+Nephew, INC. | $70.92 | 2019-2023 | Stravix Pl, Grafix Pl |
| Integra Lifesciences Corporation | $68.53 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $59.14 | 2023-2024 | Nuzyra |
| Melinta Therapeutics, LLC | $54.88 | 2019-2022 | |
| Abbvie INC. | $51.81 | 2023-2024 | Dalvance |
| Convatec INC. | $43.40 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $42.93 | 2019 | |
| Orthofix Medical, INC. | $39.95 | 2023-2025 | Physio-Stim |
| Bioventus LLC | $35.44 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $32.87 | 2024 | |
| Sebela Pharmaceuticals INC. | $28.84 | 2019-2021 | |
| Nevro Corp. | $25.38 | 2022 | |
| Grt US Holding, INC. | $23.62 | 2022 | |
| Hartmann USA, INC. | $16.64 | 2023 | Zetuvit Plus |
| Ibsa Pharma INC. | $15.76 | 2024 | Tirosint, Licart |
| Advanced Oxygen Therapy INC. | $15.18 | 2024 | Topical Oxygen Chamber For Extremities |
| Kowa Pharmaceuticals America, INC. | $13.35 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Baskhron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.